关于“利培酮对D-氨基酸氧化酶活性的影响——作为治疗精神分裂症新作用机制的一种假说”的评论 - Suppr | 超能文献

Comments on 'The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia'.

作者信息

Hashimoto Kenji

出版信息

J Psychopharmacol. 2010 Jul;24(7):1133-4. doi: 10.1177/0269881109348177. Epub 2009 Nov 25.

DOI:10.1177/0269881109348177

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Comments on 'The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia'.关于“利培酮对D-氨基酸氧化酶活性的影响——作为治疗精神分裂症新作用机制的一种假说”的评论

J Psychopharmacol. 2010 Jul;24(7):1133-4. doi: 10.1177/0269881109348177. Epub 2009 Nov 25.

2

The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia.利培酮对 D-氨基酸氧化酶活性的影响：一种治疗精神分裂症新作用机制的假说。

J Psychopharmacol. 2010 Jul;24(7):1055-67. doi: 10.1177/0269881109102644. Epub 2009 Mar 27.

3

Commentary: genome-based CNS drug discovery: D-amino acid oxidase (DAAO) as a novel target for antipsychotic medications: progress and challenges.述评：基于基因组的中枢神经系统药物发现：D-氨基酸氧化酶（DAAO）作为抗精神病药物的新靶点：进展与挑战

Biochem Pharmacol. 2009 Dec 1;78(11):1360-5. doi: 10.1016/j.bcp.2009.06.108. Epub 2009 Jul 8.

4

Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia.甘氨酸转运体I抑制剂N-甲基甘氨酸（肌氨酸），添加到抗精神病药物中用于治疗精神分裂症。

Biol Psychiatry. 2004 Mar 1;55(5):452-6. doi: 10.1016/j.biopsych.2003.09.012.

5

Drug discovery strategies and the preclinical development of D-amino-acid oxidase inhibitors as antipsychotic therapies.D- 氨基酸氧化酶抑制剂作为抗精神病疗法的药物发现策略和临床前开发。

Expert Opin Drug Discov. 2018 Oct;13(10):973-982. doi: 10.1080/17460441.2018.1524459. Epub 2018 Sep 22.

6

Recent advances in the discovery of D-amino acid oxidase inhibitors and their therapeutic utility in schizophrenia.D- 氨基酸氧化酶抑制剂的发现进展及其在精神分裂症中的治疗用途。

Curr Pharm Des. 2011;17(2):103-11. doi: 10.2174/138161211795049633.

7

The discovery of fused pyrrole carboxylic acids as novel, potent D-amino acid oxidase (DAO) inhibitors.新型强效D-氨基酸氧化酶（DAO）抑制剂——稠合吡咯羧酸的发现。

Bioorg Med Chem Lett. 2008 Jun 1;18(11):3386-91. doi: 10.1016/j.bmcl.2008.04.020. Epub 2008 Apr 13.

8

Effects of typical antipsychotic drugs and risperidone on the quality of sleep in patients with schizophrenia: a pilot study.典型抗精神病药物和利培酮对精神分裂症患者睡眠质量的影响：一项初步研究。

J Psychiatry Neurosci. 1999 Sep;24(4):333-7.

9

In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties.AS057278的体外和体内药理学特性，一种具有潜在抗精神病特性的选择性D-氨基酸氧化酶抑制剂。

Eur Neuropsychopharmacol. 2008 Mar;18(3):200-14. doi: 10.1016/j.euroneuro.2007.06.006. Epub 2007 Aug 2.

10

Risperidone in acute and long-term therapy of schizophrenia--a clinical profile.利培酮用于精神分裂症的急性和长期治疗——临床概况

Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jan;28(1):15-23. doi: 10.1016/S0278-5846(03)00164-7.